寶沙發展(01069.HK):針對公司的清盤呈請被撤銷
格隆匯10月29日丨寶沙發展(01069.HK)公吿,公司宣佈,呈請人及公司透過同意傳票方式提出撤銷呈請的聯合申請後,高等法院已於2021年10月4日作出命令,其中包括撤銷針對公司的該呈請。
公司謹此強調,儘管於香港提出撤銷及解除該呈請,凌鋒教授在開曼羣島提交針對公司的清盤呈請及委任共同臨時清盤人仍未取銷。公司已到期的債務尚未償還,而公司董事會目前有意作出持續努力,與合適白武士協定實施綜合重組計劃及解決公司的債務問題。董事會將繼續監察重組進度及向共同臨時清盤人尋求專業意見和協助,以及評估公司及建議重組的狀況和前景,以決定將不時採取的合適行動。
繼續停牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.